INVIVODATA ANNOUNCES FIRST INTEGRATION OF DEVICES IN A CLINICAL TRIAL

Invivodata inc., the industry leader in patient reported outcomes (PRO) solutions for clinical research, today announced the first integration of data from ACCU-CHEK(R) blood glucose meters from Roche Diagnostics with the DiaryPRO(TM) handheld patient diary from invivodata during a clinical trial. This advance was achieved using SyncPRO(TM), invivodata's integration module for improving the accuracy of all patient-reported measures in clinical trials.
Genetic Engineering News